Logo image
Objective monitoring of mTOR inhibitor therapy by Three-Dimensional facial analysis
Journal article   Open access   Peer reviewed

Objective monitoring of mTOR inhibitor therapy by Three-Dimensional facial analysis

G.S. Baynam, M. Walters, H. Dawkins, M. Bellgard, A.R. Halbert and P. Claes
Twin Research and Human Genetics, Vol.16(4), pp.840-844
2013
pdf
Objective_monitoring_of_mTOR_inhibitor.pdfDownloadView
Published (Version of Record) Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

With advances in therapeutics for rare, genetic and syndromic diseases, there is an increasing need for objective assessments of phenotypic endpoints. These assessments will preferentially be high precision, non-invasive, non-irradiating, and relatively inexpensive and portable. We report a case of a child with an extensive lymphatic vascular malformation of the head and neck, treated with an mammalian target of Rapamycin (mTOR) inhibitor that was assessed using 3D facial analysis. This case illustrates that this technology is prospectively a cost-effective modality for treatment monitoring, and it supports that it may also be used for novel explorations of disease biology for conditions associated with disturbances in the mTOR, and interrelated, pathways.

Details

Metrics

208 File views/ downloads
79 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.49 Dentistry & Oral Medicine
1.49.464 Orthodontic Treatment
Web Of Science research areas
Genetics & Heredity
Obstetrics & Gynecology
ESI research areas
Molecular Biology & Genetics
Logo image